Hydroxyapatite (HAp)—[Ca10 (PO4)6(OH) 2] has a similar chemical composition to bone material, making it the main mineral supplement in bone-making. Due to its high biocompatibility, hydroxyapatite is widely used in the repair of bone deficiencies and in the production of dental or orthopedic implants. In this research, hydroxyapatite nanopowder was synthesized using a hydrothermal technique. Fourier Transform Infrared Spectroscopy (FTIR) and transmission electron microscopy (TEM) were used to investigate the chemical structure and morphology of the synthesized hydroxyapatite powder. X-ray diffraction (XRD) was used to evaluate the phase analysis of HAp nanopowder. In addition, bioactivity HAp assessment was conducted by scanning electron microscopy (SEM) attached with Energy Dispersive X-Ray Spectroscopy (EDX) analysis. Response Surface Methodology (RSM) with central composite design (CCD) was used in order to determine the optimal conditions for yield, size, and crystallinity. Three independent variables (pH, temperature, and hydrothermal treatment time) were investigated. The yield was observed to increase in alkaline conditions; pH showed the greatest influence on the yield, size, and crystallinity of the synthesized hydroxyapatite, based on Analysis of Variance. The results of bioactivity evaluation are showed high bioactivity due to the formation of apatite on the surface of the synthesized nanopowder.

Recently, composite scaffolding has found many applications in hard tissue engineering due to a number of desirable features. In this present study, hydroxyapatite/bioglass (HAp/BG) nanocomposite scaffolds were prepared in different ratios using a hydrothermal approach. The aim of this research was to evaluate the adhesion, growth, viability, and osteoblast differentiation behavior of human Wharton’s-jelly-derived mesenchymal stem cells (hWJMSCs) on HAp/BG in vitro as a scaffold for application in bone tissue engineering. Particle size and morphology were investigated by TEM and bioactivity was assessed and proven using SEM analysis with hWJMSCs in contact with the HAp/BG nanocomposite. Viability was evaluated using PrestoBlueTM assay and early osteoblast differentiation and mineralization behaviors were investigated by ALP activity and EDX analysis simultaneously. TEM results showed that the prepared HAp/BG nanocomposite had dimensions of less than 40 nm. The morphology of hWJMSCs showed a fibroblast-like shape, with a clear filopodia structure. The viability of hWJMSCs was highest for the HAp/BG nanocomposite with a 70:30 ratio of HAp to BG (HAp70/BG30). The in vitro biological results confirmed that HAp/BG composite was not cytotoxic. It was also observed that the biological performance of HAp70/BG30 was higher than HAp scaffold alone. In summary, HAp/BG scaffold combined with mesenchymal stem cells showed significant potential for bone repair applications in tissue engineering.

Nanosilica was surface modified with polyaniline and incorporated into polyurethane to form a polymer matrix capable of entrapping a liquid electrolyte and functioning as quasi-solid-state electrolyte in the dye-sensitized solar cells. The effect on the S−PANi distribution, surface morphology, thermal stability, gel content, and structural change after varying the PEG molecular weight of the polyurethane matrix was analyzed. Quasi-solid-state electrolytes were prepared by immersing the polyurethane matrix into a liquid electrolyte and the polymer matrix absorbency, conductivity, and ion diffusion were investigated. The formulated quasi-solid-state electrolytes were applied in dye-sensitized solar cells and their charge recombination, photovoltaic performance, and lifespan were measured. The quasi-solid-state electrolyte with a PEG molecular weight of 2000 gmol−1 (PU−PEG 2000) demonstrated the highest light-to-energy conversion efficiency, namely, 3.41%, with an open-circuit voltage of 720 mV, a short-circuit current of 4.52 mA cm−2, and a fill factor of 0.63.

Composite scaffolds of hydroxyapatite (HAp) nanoparticles and bioactive glass (BG) have been applied as appropriate materials for bone tissue engineering. In this study, hydroxyapatite/bioglass cement in different ratios was successfully fabricated. To prepare HAp and HAp/BG cement, synthesized HAp and HAp/BG powder were mixed in several ratios, using different concentrations of sodium hydrogen phosphate (SP) and water as the liquid phase. The liquid to powder ratio used was 0.4 mL/g. The results showed that setting time increased with BG content in the composite. The results also showed that with the addition of bioglass to the HAp structure, the density decreased and the porosity increased. It was also found that after immersion in simulated body fluid (SBF) solution, the compressive strength of the HAp and HAp/BG cements increased with BG concentration up to 30 wt.%. SEM results showed the formation of an apatite layer in all selected samples after immersion in SBF solution. At 30 wt.% BG, greater nucleation and growth of the apatite layer were observed, resulting in higher bioactivity than pure HAp and HAp/BG in other ratios.

Composite scaffolds of hydroxyapatite (HAp) nanoparticles and bioactive glass (BG) were applied as an appropriate selection for bone tissue engineering. To this end, HAp/BG composite was synthesized by a hydrothermal method using Design of Experiments (DOE) with a combined mixture–process factor design for the first time. The input variables were hydrothermal temperature at three levels (i.e., 100, 140, 180 °C) as a process factor and two mixture components in three ratios (i.e., HAp 90, 70, 50; BG 50, 30, 10). The degree of crystallinity and crystal size in the composite were the output variables. XRD showed that only a small fraction of BG was crystallized and that a wollastonite phase was produced. The XRD results also revealed that incorporation of Si into the HAp structure inhibited HAp crystal growth and restricted its crystallization. The FTIR results also showed that the intensity of the hydroxyl peak decreased with the addition of silicon into the HAp structure. DOE results showed that the weight ratio of the components strongly influenced the crystal size and crystallinity. SEM and FTIR results identified the greatest bioactivity and apatite layer formation in the Si-HAp sample with an HAp70/BG30 ratio after 14 days immersion in simulated body fluid (SBF) solution, as compared to other ratios and HAp alone. Therefore, the combination of HAp and BG was able to yield a HAp/BG composite with significant bioactivity.